Indication
Anxiety Disorder
6 clinical trials
8 products
1 drug
Clinical trial
Intranasal Remimazolam for Premedication in Pediatric Patients: a Double-blinded Randomized Clinical TrialStatus: Completed, Estimated PCD: 2022-02-28
Product
RemimazolamProduct
DexmedetomidineClinical trial
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.1. (Pharmacological Manipulation)Status: Not yet recruiting, Estimated PCD: 2025-03-31
Clinical trial
Disulfiram Combined With Lorazepam for Treatment of Patients With Alcohol Dependence and Primary or Secondary Anxiety DisorderStatus: Completed, Estimated PCD: 2012-08-01
Product
Disulfiram + LorazepamClinical trial
Cognitive vs. Emotional Psycho-Pharmacological Manipulations of Fear vs. AnxietyStatus: Completed, Estimated PCD: 2021-10-07
Product
PropranololProduct
MethylphenidateDrug
VarlilumabClinical trial
Double-Blind, Randomized, Placebo-Controlled Trial of Naproxen Sodium for the Treatment of Obsessive Compulsive Symptoms in Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infections (PANDAS)Status: Recruiting, Estimated PCD: 2024-10-31
Product
NaproxenClinical trial
A Multicenter Randomized Controlled Study of Pulse Magnetotherapy Combined Medication in the Treatment of Patients With Anxiety Disorder and InsomniaStatus: Recruiting, Estimated PCD: 2025-11-30